Role of self-carriers in the immune response and tolerance. I. B-cell unresponsiveness and cytotoxic T-cell immunity induced by haptenated syngeneic lymphoid cells by unknown
Brief Definitive Report 
ROLE OF SELF-CARRIERS IN THE IMMUNE RESPONSE 
AND TOLERANCE 
I.  B-Cell Unresponsiveness and Cytotoxic T-Cell Immunity 
Induced by Haptenated Syngeneic Lymphoid Cells* 
BY DAVID  W. SCOTT$ AND CAROL  ANN  LONG 
(From the Division of Immunology,  Department of Microbiology and Immunology,  Duke Medical 
Center, Durham,  North Carolina, 27710) 
Discrimination between "self' and "non-self' is the cornerstone upon which immunol- 
ogy is built. Thus, self-antigens are by definition nonimmunogenic;  moreover, haptens 
coupled to self-carriers are generally quite tolerogenic. This is best exemplified by the 
superior tolerogenicity of haptenated isologous serum proteins and cells (1-5).~  On the 
other hand, the conjugation  ofhaptens to isologous protein or cellular carriers may create 
new antigenic determinants, which can be immunogenic (6, 7) under certain conditions. 
For example, the exposure of mouse lymphocytes to haptenated syngeneic spleen cells in 
vitro induces the generation of cytotoxic T cells directed at hapten-modified H-2 determi- 
nants (7).  Since we  had  previously shown that haptenated spleen cells are  excellent 
tolerogens in vivo for a humoral immune response (5), 1 it appeared that hapten-modified 
self lymphoid cells may produce differential B-cell tolerance and T-cell immunity. In the 
present report,  we  have tested this prediction. Our results suggest that,  in the same 
culture, trinitrophenylated (TNP)-spleen cells will block the humoral response to TNP 
while inducing a cytotoxic T-cell response. The importance of the differential perception 
and response to modified self by various lymphocyte subpopulations is discussed. 
Materials and Methods 
Animals.  Inbred male C3H/St  (West  Seneca Breeding Labs, Buffalo,  N.  Y.), C57BL/6, and 
C3H/He  × DBA/2 (C3D2) mice (The Jackson Laboratory, Bar Harbor, Maine) were used at 6-10 
wk of age. 
Preparation of I-Iaptenated Spleen Cells.  Trinitrophenylated spleen cells (TNP-SC) were pre- 
pared,  with slight modification, according to Shearer et al.  (7)  as follows: spleens from  age- 
matched syngeneic mice were washed, treated for 2 min with Tris-buffered ammonium chloride to 
lyse erythrocytes, rewashed, and adjusted to 108 SC/ml phosphate-buffered saline (PBS). 4 ml of 10 
mM recrystallized trinitrobenzene sulfonic acid  (TNBS;  Nutritional Biochemicals,  Cleveland, 
Ohio) was added to each 1 ml SC (108) and rocked gently for 20 rain at room temperature. These 
TNP-SC  were  washed  extensively with sterile medium, exposed  to  2,000 R "~,-irradiation, re- 
washed, and used as described below. 
Tissue  Culture.  Normal SC  at  107/culture were added  to the inner chambers of Marbrook 
vessels +-  antigen and cultured for 3-5 days. The outer chamber contained 10-12 ml minimal 
essential medium, 10% fetal calf serum (Flow Laboratories, Inc., Rockville, Md., lot no. 1055971), 
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nonessential amino acids, vitamins, antibiotics, and 5  x  10  5 M  mercaptoethanol as described 
earlier (8). For plaque-forming cell (PFC) responses, two kinds of antigenic challenge were used. 
"T-independent" responses were elicited with trinitrophenylated aminoheptyl ficoll (TNP-ficoll); 
"T-dependent" responses were induced with trmitrophenylated red blood cells (see Results). In the 
latter case, donor mice were primed 4 days before culture with 1-4  x  10  ~ red blood cells as de- 
scribed by Kettman and Dutton (9). 
Assays for Immune Responses.  Plaque-forming cell responses of individual triplicate cultures 
to TNP-goat RBC (TNP-GRBC), GRBC, or donkey RBC were performed on day 3-4 either by the 
Cunningham slide technique (10) or a modified Jerne plate method. Determination of killer cell 
activity was done on day 5 as described earlier (8,  11)  using 51chromium-labeled TNP-clone 1D 
(CL1D)  (Ho2  k L-cell derivative) or ~Cr-CL1D as targets. 
Results 
Inhibition of the Antibody Response by Haptenated Spleen Cells.  Previous 
studies in our laboratory had shown that pretreatment of rats with syngeneic 
TNP-spleen cells intravenously (i.v.) dramatically reduced the ability of these 
animals to respond to TNP-protein challenge in adjuvant as measured by direct 
and indirect PFC  (5). 1 Since  Shearer  and co-workers have found that TNP- 
syngeneic SC stimulate the generation of cytotoxic T  cells in vitro (7), it was 
important to determine in the same system whether these differences repre- 
sented differential recognition of the same conjugate by B- and T-cell subpopula- 
tions. To test this, 107 spleen cells from C3H/St mice were cultured alone or with 
106  irradiated  TNP-SC  _+  various  doses  of TNP-ficoll.  The  results  (Table  I) 
showed that the presence of TNP-SC totally blocked the in vitro responses of 
normal C3H SC to TNP-ficoll at doses up to 10 ng; the response to 100 ng TNP- 
ficoll was inhibited to less than 20% of the response of control cultures. No effect 
on the response to GRBC was observed, indicating a  specific inhibition of the 
anti-TNP response. Additional experiments have demonstrated that TNP-SC do 
not inhibit the response to non-cross-reactive (8) fluorescein-ficoll either in vitro 
or  in vivo,  while the  response  to TNP-ficoll  is  consistently reduced by such 
treatment (data not shown). 
To further document the  suppression by haptenated spleen cells,  we  have 
examined the effect of TNP-SC on the in vitro response to TNP-RBC, a highly T- 
cell-dependent response (9). As shown in Table II, the presence of 106 TNP-SC 
inhibited the anti-TNP PFC response in RBC-primed spleen cells more than 
75%; again, no significant effect of TNP-SC was seen on the anti-RBC response. 
Stimulation of Cytotoxic T Cells and Inhibition of B-Cell Responses by TNP- 
Spleen Cells.  Since the cultivation of normal spleen cells with TNP-SC stimu- 
lates the generation of cytotoxic T cells specific for hapten-modified H-2 determi- 
nants (7, 12), we next examined whether TNP-SC could simultaneously inhibit 
the PFC response of normal SC, while stimulating a "TNP-specific" cytotoxic T- 
cell response. The results in Table III indicate that this is indeed the case. C3H/ 
St spleen cells cultured with TNP-ficoll (group D) respond well in terms of PFC, 
but yield no significant killer cell activity. The presence of 106 TNP-SC totally 
blocks the PFC responsiveness of C3H spleen cells (group C) while stimulating a 
good cytotoxic response in the 51Cr release assay. As also observed by Shearer 
(personal communication), TNP-SC do not stimulate a significant PFC response 
alone, but consistently induce TNP-specific killers (group B). 
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TABLE I 
Effect of TNP-SC on the In Vitro PFC Response to TNP-Ficoll* 
Addltmnal cells 
PFC  -+ SE/culture (day 4) 
TNP-ficoll dose 
0.02% GRBC 
0 ng  I ng  10 ng  100 ng 
None  0  484 _+  123  995 -+  79  1,273 -+  112  2,043 -+  162 
106 TNP-SC  30 -+  7  6  -+  32  40 _+  75  259 _+  55  1,900 _+  108 
*  1 ×  l0  T normal C3H/St spleen cells were cultured m  Marbreok vessels with various doses of TNP-ficoll -+ TNP-C3H SC (10~). 
TABLE II 
Effect of TNP-Spleen Cells on the In Vitro PFC Response to TNP-Red Blood 
Cells* 
Experiment  l0  s TNP-SC 
PFC/control 
vs TNP  vs GRBC  vs. DRBC 
1  +  362 -+  143  9,250 -+  1,265 
4,615 ±  1,205  7,175 -+  980 
2  +  1,5(~ -+  675 
6,230 ±  1,575 
190 -+  96 
437 -+  148 
* In experiment 1, C3D2 mice were premed with 4 ×  106 goat RBC 1 p. on day -4 and cultured on day 0 with 4 ×  l0  s 
TNP-GRBC -+ TNP-SC (C3D2), In experiment 2, C57BL/6 mice were primed with 10  e donkey RBC l p  on day -4 
and cultured on day 0 with 4  x  l0  s TNP-DRBC -+  TNP-SC (C57BL). 
TABLE UI 
Effect of TNP-Spleen Cells on the In Vitro Generation of TNP-Specific PFC and 
Cytotoxic Cells* 
Group  TNP-ficoll  TNP-SC  PFC  -+ SE/culture 
Percent specific  5~Cr release (± range) 
vs. TNP-CLID  vs CLID 
A  -  -  0*  2 2  ±  2  -0.4  ±  1.2 
B  -  +  30 -+  23  27 2  -+  1.4  1.2 ±  2.7 
C  +  +  0  297-+36  44-+0.3 
D  +  -  550 -+  259  7.2 -+  5.4  -0 1  -+  3 3 
* l0  T  C3H spleen  cells  cultured  m  Marbrook vessels -+ TNP-SC (106)  and TNP-ficoll (50  ng).  PFC assay performed  on  day 3 and  5~Cr 
release assay on day 5 [m whlch S~Cr released = (experlment cpm - background cpm)/(HCl releasable cpm) ×  100] 
Background PFC subtracted (110 _+ 8) 
inhibit the PFC response and induce cytotoxic T cells, C3H/St spleen cells were 
cultured with TNP-ficoll _+ various numbers of TNP-SC. The results (Table IV) 
showed that as few as l0  s TNP-SC could specifically inhibit the PFC response by 
80%  while simultaneously inducing a  maximal killer cell response.  Interest- 
ingly, the decrease in suppression and killer cell induction occurred at the same 
dose of TNP-SC. 
Discussion 
The induction of tolerance with haptenated nonimmunogenic carriers is well 
established. Haptens coupled to isologous serum proteins, especially IgG (2),  or 
haptenated  lymphoid or red cells are effective tolerogens  as measured by the 
humoral immune response (1-3,  13) 1 and contact hypersensitivity  (CH)  (3, 4). 1 
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TABLE  IV 
Titration of TNP-SC: Inhibition of the Anti-TNP Response In Vitro* 
No. TNP-SC added 
PFC/culture 
vs  TNP  vs  GRBC 
Cytotoxlclty 
S'Cr release  vs 
TNP-L cells 
% 
106  206  ±  168  6,283  70 
3  x  10  s  584  ±  146  6,867  74 
1  ×  i0  5  484 ±  154  7,100  72 
3  x  104  1,267  ±  463  4,584  45 
NSC  2,317  ±  351  5,300  0 
* Spleen cells from C3H/St mice were cultured with 50 ng TNP-ficoll plus various numbers of TNP-SC  Rephcate 
cultures were incubated with 0.02% GRBC (column 2) or TNP-SC (no ficoll) for kdler cell induction Icolumn 3) 
PFC day 4  Kdler assay day 5. 
may function as tolerogens for several reasons: their persistence in the circula- 
tion or at the cell surface (14), their favorable "homing" patterns to B- or T-cell 
areas (15), associative recognition (e.g., IgG by Fc receptors), or finally by the 
activation  of suppressor  cells  to  autologous antigens  (16). At  present,  it  is 
difficult to distinguish among these mechanisms; moreover, they may not be 
mutually exclusive. 
In contrast to these in vivo tolerance observations, the cultivation of normal 
spleen cells with haptenated syngeneic cells in vitro results in the generation of 
cytotoxic T cells specific for hapten-modified histocompatibility antigens (7, see 
reference 12). Therefore, haptenated syngeneic cells are tolerogenic for humoral 
and CH responses in vivo, but are immunogenic for a cytotoxic T-cell response in 
vitro. In addition, Naor et al. have found that haptenated spleen cells (prepared 
after affinity labeling) would block PFC induction in vitro (17). In the present 
report, we have examined the PFC and killer cell responses in the same culture 
of normal spleen cells in the presence or absence of haptenated spleen cells. We 
have found that the  same preparation  of TNP-spleen cells will block a  PFC 
response while simultaneously stimulating a cytotoxic T-cell response in vitro. 
The inhibition of the PFC response is probably not due to the presence of free 
hapten since monovalent hapten does not inhibit PFC responses except at very 
high  levels.  Moreover,  titration  of TNP-SC  in  vivo  1 or  in  vitro  (Table  IV) 
indicated that  these  cells  were  far  more  tolerogenic than equivalent  molar 
amounts of TNP-isologous Ig, for example (data not shown). While the mecha- 
nism of B-cell unresponsiveness in this system is unknown, it is clear that the 
results of an encounter with modified self in vitro can be clearly different for B 
cells and T (Ly 2,3) cells. Since the T cells involved in CH may also be rendered 
tolerant by the appropriate exposure to modified self (4), we must consider these 
Ly 1 (18) cells in any discussion of differential tolerance induction. One interpre- 
tation of the contrasting results is that there are different triggering signals or 
thresholds for each of these populations and what is immunogenic for one may 
be tolerogenic for another. Alternatively, both B and TcH cells have receptors for 
modified self but cannot be triggered (receptor blockade?) or are inhibited from 
responding by the simultaneous generation of cytotoxic (suppressor?) T  cells. 
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Summary 
Normal spleen cells cultured with TNP-modified syngeneic spleen cells fail to 
mount an anti-TNP PFC response to TNP-ficoll or TNP-red blood cells, but go on 
to  generate  cytotoxic  T  cells  directed  at  hapten-modified  H-2,  These  results 
suggest that hapten-modified spleen cells may differentially induce B-ceU toler- 
ance and T- (Ly 2,3) cell immunity. The differential response to modified self by 
lymphocyte subpopulations  is discussed. 
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